CRL
Charles River Laboratories
294.40$
+6.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.89 | 19.63 | 19.51 | 19.79 | 19.58 | 19.60 | 19.35 | 20.93 | 20.33 | 20.20 | 20.34 | 20.71 | 82.48 | |
| 12.88 | 12.58 | 12.86 | 12.97 | 12.81 | 14.05 | 13.11 | 13.69 | 13.48 | 13.95 | 14.64 | 13.21 | 55.89 | |
| 7.01 | 7.05 | 6.65 | 6.82 | 6.77 | 5.56 | 6.25 | 7.24 | 6.85 | 6.26 | 5.71 | 7.49 | 26.59 | |
| 3.41 | 3.82 | 3.59 | 3.27 | 3.86 | 3.83 | 3.50 | 3.88 | 3.59 | 3.81 | 3.26 | 4.72 | 15.54 | |
| 4.08 | 4.48 | 4.22 | 3.90 | 4.49 | 8.84 | 4.78 | 5.21 | 4.15 | 3.81 | 3.26 | 5.02 | 16.41 | |
| 2.94 | 2.57 | 2.43 | 2.93 | 2.28 | -3.28 | 1.47 | 2.03 | 2.71 | 2.44 | 2.45 | 2.47 | 10.18 | |
| 0.65 | 0.65 | 0.68 | 0.63 | 0.59 | 0.55 | 0.55 | 0.61 | 0.51 | 0.48 | 0.55 | 0.63 | 2.19 | |
| 2.19 | 4.04 | 1.91 | 2.31 | 1.77 | -4.24 | 0.71 | 1.45 | 1.76 | -5.98 | -0.61 | 1.10 | -3.79 | |
| 0.48 | 0.38 | 0.47 | 0.49 | 0.41 | -0.06 | 0.20 | 0.38 | 0.64 | -0.36 | -0.31 | 1.11 | 1.09 | |
| 1.69 | 3.62 | 1.30 | 1.74 | 1.33 | -4.22 | 0.50 | 1.06 | 1.10 | -5.62 | -0.30 | -0.03 | -4.92 | |
| 4.37 | 6.25 | 4.23 | 4.60 | 4.07 | -1.69 | 3.62 | 4.48 | 4.00 | -3.90 | 1.31 | 3.11 | 4.55 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.